ECO 2025 Symposium: Precision medicine for obesity
In the final year of our IMI Public-Private Partnership SOPHIA, we are excited to showcase our research, celebrate our achievements and explore the future implications of SOPHIA on the future of obesity care. We are pleased to announce this year's symposium at the 32nd European Congress on Obesity (ECO), hosted in collaboration with SOPHIA and Maastricht University.
SOPHIA has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 875534. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA and T1D Exchange, Breakthrough T1D (JDRF), and Obesity Action Coalition.